The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques

Journal of Experimental Medicine

Volumn 188, Issue 6, 1998, Pages 1159-1171

  Karlsson, Gunilla B ^a   Halloran, Matilda ^a   Schenten, Dominik ^a   Lee, Juliette ^a   Racz, Paul ^c   Tenner Racz, Klara ^c   Manola, Judith ^a   Gelman, Rebecca ^a   Etemad Moghadam, Bijan ^a   Desjardins, Elizabeth ^a   Wyatt, Richard ^a   Gerard, Norma P ^a   Marcon, Luisa ^a,d   Margolin, David ^b   Fanton, John ^e   Axthelm, Michael K ^e   Letvin, Norman L ^b   Sodroski, Joseph ^a,b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CD4+ T lymphocyte depletion; Envelope glycoprotein; Pathogenesis; Rhesus macaques; Simian human immunodeficiency virus

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MACACA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS ENVELOPE;

ANIMALS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CHIMERA; GIANT CELLS; HIV-1; HUMANS; LYMPH NODES; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MACACA MULATTA; NEUTRALIZATION TESTS; PROTEIN STRUCTURE, TERTIARY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0032555938     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.6.1159     Document Type: Article

References (48)

1. Barré-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, et al. 1983. Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220:868-871.
2. Gallo, R.C., S.Z. Salahuddin, M. Popovic, G.M. Shearer, M. Kaplan, B.F. Haynes, T.J. Palker, R. Redfield, J. Oleske, B. Safai, et al. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 224:500-503.
3. Letvin, N.L. 1992. Animal models for the study of human immunodeficiency virus infections. Curr. Opin. Immunol. 4: 481-485.
4. Daar, E.S., T. Moudgil, R.D. Meyer, and D.D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324:961-964.
5. Clark, S.J., M.S. Saag, D. Decker, S. Campbell-Hill, J.L. Robertson, P.J. Veldkamp, J.C. Kappes, B.H. Hahn, and G.M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
6. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:123-126.
7. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117-122.
8. Sodroski, J., W.C. Goh, C. Rosen, K. Campbell, and W.A. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature. 322:470-474.
9. Lifson, J., M. Feinberg, G. Reyes, L. Rabin, B. Banapour, S. Chakrabarti, B. Moss, F. Wong-Staal, K. Steimer, and E. Engelman. 1986. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Science. 323:725-728.
10. Koga, Y., M. Sasaki, K. Nakamura, G. Kimura, and K. Nomoto. 1990. Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4-human cell lines. J. Virol. 64:4661-4671.
11. Cao, J., I-W. Park, A. Cooper, and J. Sodroski. 1996. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70:1340-1354.
12. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:767-768.
13. Dalgleish, A.G., P.C.L. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:763-767.
14. Deng, H., D. Unutmaz, V.N. Kewal Ramani, and D.R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:296-300.
15. Feng, Y., C. Broder, P. Kennedy, and E. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:872-877.
16. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. MacKay, G. Larosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
17. Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.M. Murphy, and E. Berger. 1996. CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1955-1958.
18. Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
19. Wu, L., N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardins, W. Newman, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:179-183.
20. Trkola, A., T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, G.P. Allaway, C. Cheng-Mayer, J. Robinson, P.J. Maddon, and J.P. Moore. 1996. CD4-independent, antibody-sensitive interaction between HIV-1 and its co-receptor CCR-5. Nature. 384:184-187.
21. Chakrabarti, L., M.C. Cumont, L. Montagnier, and B. Hurtrel. 1994. Variable course of simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J. Virol. 64:6634-6642.
22. Mellors, J.W., C. Rinaldo, P. Gupta, R. White, J. Todd, and L.A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1167-1170.
23. Ruprecht, R.M., T. Baba, R. Rasmussen, Y. Hu, and P. Sharma. 1996. Murine and simian retrovirus models: the threshold hypothesis. AIDS (London). 10:533-40.
24. Lifson, J., M. Nowak, S. Goldstein, J. Rossio, A. Kinter, G. Vasquez, T. Wiltrout, C. Brown, D. Schneider, L. Wahl, et al. 1997. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection J. Virol. 71:9508-9514.
25. Desrosiers, R.C., J. Lifson, J. Gibbs, S. Czajak, A. Howe, L. Arthur, and R.P. Johnson. 1998. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1431-1437.
26. Reimann, K.A., K. Tenner-Racz, P. Racz, D.C. Montefiori, Y. Yasutomi, W. Lin, B.J. Ransil, and N.L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus macaques. J. Virol. 68:2362-2370.
27. Novembre, F.J., M. Saucier, D.C. Anderson, S.A. Klumpp, S.P. O'Neil, C.R. Brown Jr., C.E. Hart, P.C. Guenthner, R.B. Swenson, and H.M. McClure. 1997. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J. Virol. 71:4086-4091.
28. Li, J., C.I. Lord, W. Haseltine, N.L. Letvin, and J. Sodroski. 1992. Infection of cynomolgus monkeys with chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquir. Immune Defic. Syndr. 5:639-646.
29. Igarashi, T., R. Shibata, F. Hasebe, Y. Ami, K. Shinohara, T. Komatsu, C. Stahl-Hennig, H. Petry, G. Hunsmann, T. Kuwata, et al. 1994. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env, and nef of HIV type 1 in macaque monkeys. AIDS Res. Hum. Retrovirus. 10:1021-1029.
30. Luciw, P.A., E. Pratt-Lowe, K.E.S. Shaw, J.A. Levy, and C. Cheng-Mayer. 1995. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA. 92:7490-7494.
31. Li, J.T., M. Halloran, C.I. Lord, A. Watson, J. Ranchalis, M. Fung, N.L. Letvin, and J.G. Sodroski. 1995. Persistent infection of macaques with simian-human immunodeficiency virus. J. Virol. 69:7061-7071.
32. Reimann, K.A., J.T. Li, G. Voss, C. Lekutis, K. Tenner-Racz, P. Racz, W. Lin, D.C. Montefiori, D.E. Lee-Parritz, Y. Lu, et al. 1996. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70:3198-3206.
33. Reimann, K.A., J.T. Li, R. Veazey, M. Halloran, I-W. Park, G.B. Karlsson, J. Sodroski, and N.L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.
34. Karlsson, G.B., M. Halloran, J. Li, I-W. Park, R. Gomila, K. Reimann, M.K. Axthelm, S.A. Iliff, N.L. Letvin, and J. Sodroski. 1997. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J. Virol. 71:4218-4225.
35. Stephens, E.B., S. Mukherjee, M. Sahni, W. Zhuge, R. Raghavan, D.K. Singh, K. Leung, B. Atkinson, Z. Li, S.V. Joag, et al. 1997. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has altered cytotropism. Virology. 231:313-321.
36. Reimann, K.A., B.C.D. Waite, D.E. Lee-Parritz, W. Lin, B. Uchanska-Ziegler, M.J. O'Connell, and N.L. Letvin. 1994. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry. 17:102-108.
37. Pachl, C., J.A. Todd, D.G. Kern, P.J. Sheridan, S.J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, et al. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquir. Immune Defic. Syndr. 8:446-454.
38. Tenner-Racz, K., H.-J. Stellbrink, J. van Lunzen, C. Schneider, H.-P. Jacobs, B. Raschdorff, G. Großschupff, R.M. Steinman, and P. Racz. 1998. The enlarged lymph nodes of HIV-1-infected asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 187:949-959.
39. Hamilton, L. 1992. Regression with Graphics: A Second Course in Applied Statistics. Duxbury Press, Belmont, CA. 41.
40. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
41. Culp, J.S., H. Johansen, B. Hellmig, J. Beck, T.J. Matthews, A. Delers, and M. Rosenberg. 1991. Regulated expression allows high level production and secretion of HIV-1 gp120 envelope glycoprotein in Drosophila Schneider cells. Biotechnology. 9:173-177.
42. Olshevsky, U., E. Helseth, C. Furman, J. Li, W.A. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
43. Voss, G., J. Li, K. Manson, M. Wynand, J. Sodroski, and N.L. Letvin. 1995. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology. 208:770-775.
44. Farzan, M., H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, et al. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
45. Burton, D.R., J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, P.W.H.I. Parren, L.S.W. Sawyer, R.M. Hendry, N. Dunlop, P.L. Nara, et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science. 266:1024-1027.
46. + T cell count for HIV-1-infected patients with advanced immunosuppression. Int. J. STD AIDS. 7:495-501.
47. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
48. Nowak, M., A. Lloyd, G. Vasquez, T. Wiltrout, L. Wahl, N. Bischofberger, J. Williams, A. Kinter, A. Fauci, V. Hirsch, and J. Lifson. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525.